RiPCoN

Grant number: RiPCoN

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $1,333,206.81
  • Funder

    European Commission
  • Principle Investigator

    Pending
  • Research Location

    Germany, Europe
  • Lead Research Institution

    Helmholtz Zentrum München
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Rapid interaction profiling of 2019-nCoV for network-based deep drug- repurpose learning (DDRL